[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AP9300542A0 - 17a and 17b-alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds - Google Patents

17a and 17b-alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds

Info

Publication number
AP9300542A0
AP9300542A0 AP93/00542A AP9300542A AP9300542A0 AP 9300542 A0 AP9300542 A0 AP 9300542A0 AP 93/00542 A AP93/00542 A AP 93/00542A AP 9300542 A AP9300542 A AP 9300542A AP 9300542 A0 AP9300542 A0 AP 9300542A0
Authority
AP
ARIPO
Prior art keywords
compounds
carboxyaromatic
alkylketone
pharmaceutical compositions
compositions containing
Prior art date
Application number
AP93/00542A
Other versions
AP412A (en
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP9300542A0 publication Critical patent/AP9300542A0/en
Application granted granted Critical
Publication of AP412A publication Critical patent/AP412A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/1993/000542A 1992-06-30 1993-06-30 17a and 17B-Alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds. AP412A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929213835A GB9213835D0 (en) 1992-06-30 1992-06-30 Compounds

Publications (2)

Publication Number Publication Date
AP9300542A0 true AP9300542A0 (en) 1993-07-31
AP412A AP412A (en) 1995-09-29

Family

ID=10717920

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000542A AP412A (en) 1992-06-30 1993-06-30 17a and 17B-Alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds.

Country Status (23)

Country Link
EP (1) EP0651643A4 (en)
JP (1) JPH08500821A (en)
KR (1) KR950702118A (en)
CN (1) CN1095382A (en)
AP (1) AP412A (en)
AU (1) AU4545993A (en)
BG (1) BG99313A (en)
BR (1) BR9306748A (en)
CA (1) CA2138956A1 (en)
CZ (1) CZ334694A3 (en)
FI (1) FI946189A (en)
GB (1) GB9213835D0 (en)
HU (1) HUT69409A (en)
IL (1) IL106158A0 (en)
MA (1) MA22927A1 (en)
MX (1) MX9303970A (en)
NO (1) NO945074L (en)
OA (1) OA10122A (en)
RU (1) RU94046378A (en)
SI (1) SI9300350A (en)
SK (1) SK159994A3 (en)
WO (1) WO1994000125A1 (en)
ZA (1) ZA934645B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
EP0646007B1 (en) * 1992-05-20 1997-08-13 Merck & Co. Inc. NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONES AS 5$g(a)-REDUCTASE INHIBITORS
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic
JP2015129095A (en) 2013-12-19 2015-07-16 ロレアル composition
BR112020016269A2 (en) * 2018-02-11 2020-12-15 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. STEROID DERIVED REGULATORS, METHOD TO PREPARE THEM AND THEIR USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors

Also Published As

Publication number Publication date
JPH08500821A (en) 1996-01-30
NO945074D0 (en) 1994-12-29
SK159994A3 (en) 1996-01-10
BR9306748A (en) 1998-12-08
MX9303970A (en) 1994-04-29
FI946189A0 (en) 1994-12-30
WO1994000125A1 (en) 1994-01-06
ZA934645B (en) 1994-01-25
BG99313A (en) 1995-09-29
EP0651643A4 (en) 1995-10-04
RU94046378A (en) 1996-10-10
IL106158A0 (en) 1993-10-20
AU4545993A (en) 1994-01-24
CA2138956A1 (en) 1994-01-06
CN1095382A (en) 1994-11-23
CZ334694A3 (en) 1995-10-18
FI946189A (en) 1994-12-30
OA10122A (en) 1996-12-18
HUT69409A (en) 1995-09-28
AP412A (en) 1995-09-29
MA22927A1 (en) 1994-04-01
NO945074L (en) 1995-02-16
KR950702118A (en) 1995-06-19
GB9213835D0 (en) 1992-08-12
EP0651643A1 (en) 1995-05-10
SI9300350A (en) 1993-12-31

Similar Documents

Publication Publication Date Title
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL104628A0 (en) Pharmaceutical compositions containing a certain steroid derivative of the pregnane series
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL110503A (en) Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation and pharmaceutical compositions containing them
GB9224855D0 (en) Pharmaceutical compositions
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
GB9209078D0 (en) Pharmaceutical compositions
HUT66864A (en) Pharmaceutical compositions
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
GB2272375B (en) Pharmaceutical composition
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
SG43083A1 (en) Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them
IL107611A0 (en) Steroid compounds and pharmaceutical compositions containing them
AP9300542A0 (en) 17a and 17b-alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds
IL104417A0 (en) Substituted dihydroindene and-acenaphthene derivatives and pharmaceutical compositions containing them
GB9209874D0 (en) Pharmaceutical compositions
ZA933638B (en) Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them
GB9226377D0 (en) Pharmaceutical compositions
IL103132A0 (en) Digitalis-like compounds and pharmaceutical compositions containing them
IL106352A0 (en) Pyridoindolo-benzodiazepines and pharmaceutical compositions containing them
IL115853A (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas and pharmaceutical compositions containing these compounds
GB9211276D0 (en) Pharmaceutical compositions
IL105740A0 (en) Tetrahydro-and perhydroisoquinoline derivatives and pharmaceutical compositions containing them